SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
韦谷兰
Lv2
120 积分
2022-03-10 加入
最近求助
最近应助
互助留言
Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Observational Study
1天前
已完结
Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC
13天前
已完结
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib
13天前
已完结
Pralsetinib: Treatment of metastatic RET fusion–positive non–small cell lung cancer
13天前
已完结
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
1个月前
已完结
Difelikefalin for Hemodialysis Patients with Pruritus in Japan
1个月前
已完结
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
2个月前
已完结
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experience
2个月前
已完结
Exposure‐Response Relationships for Pralsetinib in Patients with RET‐Altered Thyroid Cancer or RET Fusion‐Positive Nonsmall Cell Lung Cancer
2个月前
已完结
Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review
2个月前
已完结
Single-cell transcriptional diversity is a hallmark of developmental potential
2年前
已采纳
点赞,速度真快
1个月前
速度真快
3个月前
感谢,速度真快
3个月前
好的,谢谢。
3个月前
你好,附件有Protocol,我需要这个,谢谢
3个月前
感谢,速度真快
4个月前
感谢,速度真快
4个月前
感谢,速度真快
4个月前
点赞,速度真快
4个月前
感谢,速度真快,帮大忙了
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论